These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 16179568)

  • 1. Fibrinolytic gene polymorphism and ischemic stroke.
    Jood K; Ladenvall P; Tjärnlund-Wolf A; Ladenvall C; Andersson M; Nilsson S; Blomstrand C; Jern C
    Stroke; 2005 Oct; 36(10):2077-81. PubMed ID: 16179568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic variants of fibrinolytic system with stroke and stroke subtypes.
    Babu MS; Prabha TS; Kaul S; Al-Hazzani A; Shafi G; Roy S; Balakrishna N; Jyothy A; Munshi A
    Gene; 2012 Mar; 495(1):76-80. PubMed ID: 22240314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts.
    Wiklund PG; Nilsson L; Ardnor SN; Eriksson P; Johansson L; Stegmayr B; Hamsten A; Holmberg D; Asplund K
    Stroke; 2005 Aug; 36(8):1661-5. PubMed ID: 16020771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator -7351C/T enhancer polymorphism is a risk factor for lacunar stroke.
    Jannes J; Hamilton-Bruce MA; Pilotto L; Smith BJ; Mullighan CG; Bardy PG; Koblar SA
    Stroke; 2004 May; 35(5):1090-4. PubMed ID: 15031453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D
    Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism frequency and plasma PAI-1 enzyme activity in patients with acute stroke.
    Kucukarabaci B; Gunes HV; Ozdemir G; Cosan D; Ozbabalik D; Dikmen M; Degirmenci I
    Genet Test; 2008 Sep; 12(3):443-51. PubMed ID: 18662099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke.
    Ding J; Nicklas BJ; Fallin MD; de Rekeneire N; Kritchevsky SB; Pahor M; Rodondi N; Li R; Zmuda JM; Harris TB
    Am Heart J; 2006 Dec; 152(6):1109-15. PubMed ID: 17161063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A-G-4G haplotype of PAI-1 gene polymorphisms -844 G/A, HindIII G/C, and -675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease.
    Adamski MG; Turaj W; Slowik A; Wloch-Kopec D; Wolkow P; Szczudlik A
    Acta Neurol Scand; 2009 Aug; 120(2):94-100. PubMed ID: 19154538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of PAI-1 and TPA genes polymorphisms to acute myocardial infarction and its outcomes in Egyptian patients.
    Abd El-Aziz TA; Rezk NA
    Cell Biochem Biophys; 2015 Jan; 71(1):227-34. PubMed ID: 25113642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the tissue-type plasminogen activator -7351C > T and plasminogen activator inhibitor 1 4G/5G gene polymorphisms in central serous chorioretinopathy.
    Malle EM; Posch-Pertl L; Renner W; Pinter-Hausberger S; Singer C; Haas A; Wedrich A; Weger M
    Ophthalmic Genet; 2018 Dec; 39(6):714-716. PubMed ID: 30442055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. tPA Alu (I/D) polymorphism associates with bacterial osteomyelitis.
    Valle-Garay E; Montes AH; Corte JR; Meana A; Fierer J; Asensi V
    J Infect Dis; 2013 Jul; 208(2):218-23. PubMed ID: 23570848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly.
    Hoekstra T; Geleijnse JM; Kluft C; Giltay EJ; Kok FJ; Schouten EG
    Stroke; 2003 Dec; 34(12):2822-8. PubMed ID: 14605330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effect of the PAI-1 4G/5G polymorphism on cholesterol levels may explain conflicting associations with myocardial infarction and stroke.
    Boncoraglio GB; Bodini A; Brambilla C; Carriero MR; Ciusani E; Parati EA
    Cerebrovasc Dis; 2006; 22(2-3):191-5. PubMed ID: 16735791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global fibrinolytic activity, PAI-1 level, and 4G/5G polymorphism in Thai children with arterial ischemic stroke.
    Natesirinilkul R; Sasanakul W; Chuansumrit A; Kadegasem P; Visudtibhan A; Wongwerawattanakoon P; Sirachainan N
    J Stroke Cerebrovasc Dis; 2014; 23(10):2566-2572. PubMed ID: 25284719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of PAI-1 4G/5G Promoter Polymorphism and Its Levels in the Development of Ischemic Stroke in Young Indian Population.
    Akhter MS; Biswas A; Abdullah SM; Behari M; Saxena R
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):1071-1076. PubMed ID: 28460568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PAI-1 4G/5G gene polymorphism and ischemic stroke: an association study and meta-analysis.
    Attia J; Thakkinstian A; Wang Y; Lincz L; Parsons M; Sturm J; McGettigan P; Scott R; Meldrum C; Levi C
    J Stroke Cerebrovasc Dis; 2007; 16(4):173-9. PubMed ID: 17689414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.